VSX2 and nervous system disorder: Moreover, characterization of the behavioural differences of C. elegans ret-1 LoF mutants means they are well suited for future high-throughput compound screens to further elucidate the molecular underpinnings of this rare neurological disorder and identify additional candidate targets for treatment.